13D/13G Filings - KALA BIO Inc. (KALA)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2022-01-10
12:54 pm
Sale		 2021-12-31 13G Kala Pharmaceuticals, Inc.
KALA		 BlackRock Inc.
BLK		 125,391
4.800%		 -1,029decrease
(-0.81%)		 Filing
History
2021-11-26
4:17 pm
Purchase		 2021-11-15 13D Kala Pharmaceuticals, Inc.
KALA		 Lagunita LLC 213,645
7.300%		 213,645increase
(New Position)		 Filing
History
2021-11-26
4:16 pm
Purchase		 2021-11-15 13D Kala Pharmaceuticals, Inc.
KALA		 Lagunita Biosciences LLC 213,645
7.300%		 213,645increase
(New Position)		 Filing
History
2021-11-24
2:27 pm
Purchase		 2021-11-15 13D Kala Pharmaceuticals, Inc.
KALA		 Blumenkranz Mark S. 213,645
7.300%		 213,645increase
(New Position)		 Filing
History
2021-10-28
4:23 pm
Purchase		 2009-02-28 13D Kala Pharmaceuticals, Inc.
KALA		 RA Capital Management, L.P. 438,461
16.850%		 3,477increase
(+0.80%)		 Filing
History
2021-10-14
5:00 pm
Sale		 2021-10-12 13G Kala Pharmaceuticals, Inc.
KALA		 ORBIMED ADVISORS LLC 0
0.000%		 -188,568decrease
(Position Closed)		 Filing
History
2021-03-01
6:09 pm
Unchanged		 2020-12-31 13G Kala Pharmaceuticals, Inc.
KALA		 ORBIMED ADVISORS LLC 188,568
8.410%		 0
(Unchanged)		 Filing
History
2021-02-12
4:53 pm
Purchase		 2020-12-31 13G Kala Pharmaceuticals, Inc.
KALA		 ORBIMED ADVISORS LLC 188,568
8.410%		 50,654increase
(+36.73%)		 Filing
History
2021-02-12
4:08 pm
Purchase		 2020-12-31 13G Kala Pharmaceuticals, Inc.
KALA		 Eventide Asset Management, LLC 138,000
6.200%		 138,000increase
(New Position)		 Filing
History
2021-02-02
3:13 pm
Purchase		 2020-12-31 13G Kala Pharmaceuticals, Inc.
KALA		 BlackRock Inc.
BLK		 126,420
5.600%		 126,420increase
(New Position)		 Filing
History
Goto Prev, 0, 1